What You Really Need to Know About Egg Freezing
By Charlotte Alter, Diane Tsai, & Francesca Trianni,
Time
| 07. 16. 2015
Untitled Document
Egg freezing has been hailed as a game-changer for women, an “insurance policy” to revitalize waning fertility, a breakthrough as revolutionary as the birth control pill. But how well does it really work?
In this week’s issue of the magazine, we took a deep dive into the promises and pitfalls of egg-freezing. If you’re reading this, you probably already know all the facts about how egg quality and quantity deteriorate with age, which is why some women consider freezing their eggs until they’re ready to use them.
Here are eight key takeaways from six months of reporting on whether procedure lives up to the hype:
1) Egg-freezing is taking off among professional women. Doctors say they’ve seen more interest in the procedure since Apple and Facebook announced last year they’d cover egg-freezing in their employee health plans, and younger women are beginning to ask about how they can preserve their fertility. In 2009, only about 500 women froze their eggs—in 2013, almost 5,000 did, according to data obtained from the Society for Assisted Reproductive Technology (SART.) Fertility...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...